Fact CheckerSign in

NCT07054749Completed

Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases

Artificial Intelligence Literacy and E-Health Literacy in Inflammatory Rheumatic Diseases: A Cross-Sectional Observational Study

Source: ClinicalTrials.gov · Last updated 14 Jul 2025

Brief summary (registry, in English)

This study aims to evaluate digital health competencies in individuals with rheumatic and degenerative joint diseases. Specifically, it assesses e-health literacy and artificial intelligence literacy, which refer to individuals' ability to access, understand, and utilize online health information and AI-based health technologies. Participants include patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, knee osteoarthritis, and healthy volunteers. The study also examines how these competencies are associated with demographic variables, anxiety, depression, and functional status. Findings may contribute to improving digital health strategies for patients with chronic musculoskeletal conditions.

Status (registry)
Completed
Study type
Observational
Enrollment
201 (actual)
First submitted
27 Jun 2025
Start date
22 Dec 2024
Primary completion date
31 May 2025
Lead sponsor
Gulseren Demir Karakilic
NCT number
NCT07054749

What you commit to

  • Study type: Observational
  • Participants enrolled: 201
  • From 22 Dec 2024 to the primary completion date, 31 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment or illiteracy
  • Presence of multiple rheumatic diseases
  • Major psychiatric disorder or neurodegenerative disease

Other

  • Unwillingness to participate
  • Use of assistive digital devices that influence e-health literacy independently

Who the study is looking for

  • Age between 18 and 65 years
  • Adequate cognitive function and literacy
  • Ability to provide written informed consent
  • For RA group: Diagnosis of rheumatoid arthritis based on ACR 2010 criteria
  • For AS group: Diagnosis of ankylosing spondylitis based on Modified New York criteria
  • For PSA group: Diagnosis of psoriatic arthritis based on CASPAR criteria
  • For OA group: Clinical and radiological diagnosis of knee osteoarthritis with symptoms ≥6 months
  • For healthy controls: No known chronic diseases or complaints

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yozgat Bozok University Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Coordinator of this site? Confirm its status
YozgatTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.